Joincare Pharmaceutical Group Industry Co., Ltd.
Joincare (Joincare Pharmaceutical Group Industry Co., Ltd) is headquartered in Shenzhen. After years of steady operation and rapid development, it has now become an innovative and scientific research-oriented comprehensive pharmaceutical group. The company has always adhered to technological innovation as its strategic basis, and its strategic goal is to build a high-barrier complex preparation technology platform. Currently, it has deployed four high-barrier complex preparation R&D platforms. It owns two large listed companies of Joincare and Livzon Pharmaceutical, more than 20 major holding subsidiaries, and currently employs nearly 13,000 people. As of the end of 2020, the company's total assets were 28.157 billion yuan and operating income was 13.522 billion yuan.
Total asset RMB
Precise Layout R&D
Attracting the well-known scientists from the world, focus on building technology platforms such as monoclonal antibody, inhaled preparation, long-term sustained-release microspheres, nano lipid microemulsion, etc., with the combination of imitation and creation, global layout, leading in China.
Mature production process
Use advanced foreign equipment such as filling machine, sterilization cabinet and pinhole leak detector to complete the injection molding, filling and sterilization in the 100,000-class clean workshop
High temperature sterilization technology
It adopts the high-temperature treatment, and the whole production process without pathogenic bacteria, mold and parasites (egg) complies with the GMP standards for health products and provides safety and health
President Jiang Zemin visited the company booth
Premier Li Peng inspected the Group
Premier Zhu Rongji inspected the Group
Official WeChat Official Account